Electrophysiology Mapping and Ablation Devices – Market Insights – United States
The US EP mapping and ablation device market will experience moderate growth through 2032, with trends varying by device segment. The COVID-19 pandemic had a significant impact on some EP ablation procedures in 2020, followed by a period of recovery. Growth in market revenues will be driven by increasing ablation procedure volumes and uptake of premium-priced devices. Innovations in this space will lead to improved outcomes and procedure growth.
This Medtech 360 Report provides comprehensive data and analysis on the state of the market for EP mapping and ablation devices in the US from 2019 through 2032.
Several new technologies are being introduced commercially, with more undergoing clinical trials.
Which technologies will enter the market going forward, and when are they expected to be launched?
How will the uptake of new devices affect pricing trends and revenue growth?
Which new competitors could enter the market? How are their technologies differentiated compared to devices available today?
What effect do and will innovative device types—like dual-energy catheters, PFA, and cryoablation—have on the overall market?
The generation of clinical data will be an important competitive factor for EP mapping and ablation devices.
What regulatory and reimbursement changes have occurred and are expected due to clinical evidence?
How has clinical data supported the use of AF ablations in expanding populations?
How will the market share dynamics of different device segments be altered by ongoing clinical trials?
Recent market developments and events in this space have had a significant impact in the EP mapping and ablation market.
What effect have mergers and acquisitions had on the market?
How will market share dynamics shift with recent events occurring in this space?
How will combining competitive efforts affect the landscape?
The changing landscape of AF treatment volumes is influencing EP ablation procedures.
How have reimbursement rates impacted the distribution of EP ablation procedures?
How does AF treatment volume growth compare to other arrhythmia types?
What level of adoption can be anticipated for various types of devices?
Table of contents
- Electrophysiology Mapping and Ablation Devices - Market Insights - United States
- COVID-19 Methodology
- Abstract
- Executive Summary
- Key Report Updates
- Electrophysiology Mapping and Ablation Device Market
- Electrophysiology Lab System Market
- Electrophysiology Diagnostic Catheter Market
- Market Highlights
- Market Definitions
- Market Forecast Data
- CAGR disclaimer
- EP Diagnostic Catheter Market, by Product Type, US (USD), 2019u20132032
- EP Diagnostic Catheter Market, by Origin, US (USD), 2019u20132032
- OEM EP Diagnostic Catheter Market, by Product Type, US (USD), 2019u20132032
- Reprocessed EP Diagnostic Catheter Market, by Product Type, US (USD), 2019u20132032
- Conventional Diagnostic Catheters
- Advanced Diagnostic Catheters
- Ultrasound Diagnostic Catheters
- Market Shares
- Competitive Insights
- Electrophysiology Ablation Catheter Market
- Market Highlights
- Market Definitions
- Market Forecast Data
- CAGR disclaimer
- EP Ablation Catheter Procedures, by Indication, US, 2019u20132032
- EP Ablation Catheter Procedures, by Product Type, US, 2019u20132032
- RF Focal Ablation Catheter Procedures, by Product Feature, US, 2019u20132032
- Irrigated-Tip RF Focal Ablation Catheter Procedures, by Product Feature, US, 2019u20132032
- EP Ablation Catheter Market, by Product Type, US (USD), 2019u20132032
- Focal Ablation Catheters
- Balloon Ablation Catheters
- Market Shares
- Competitive Insights
- Electrophysiology Accessory Device Market
- Appendix
Zsuzsa Lindenmaier is a senior analyst on the Cardiovascular Medtech Insights team at Clarivate. Zsuzsa holds a Bachelor’s of Science in Neuroscience from the University of Florida and earned her PhD from the Department of Medical Biophysics at the University of Toronto.